Tag Archives: BIOTECH

Building the Case for Biotechnology Booksigning Today at BIO

Thanks to Yali (BIO Official Blogger) for reminding us that Mark Ahn, Michael Alvarez, and Anne York, the editors of Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business will be signing books today at the 2011 BIO International Convention in Washington DC from 3:00-4:30 pm in the BIO bookstore.

Events  |  Leave a comment  |  Email This Post
Tags: , ,

BIO CEO Jim Greenwood in Washington Business Journal

JimGreenwood

Jeff Porro’s recent article, “Speaking to Rise”, in the Washington Business Journal features an interview with Biotechnology Industry Organization (BIO) President and CEO, Jim Greenwood. Jim will be giving the keynote address for this year’s BIO International Convention in DC June 27-30, and suggests that the best way to discuss difficult topics like biotechnology is to “put a human face on the subject matter” and to make the material relatable to the audience. When addressing Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIOtechNOW: Where the biotech industry meets online

JimGreenwood

As the biotech industry prepares to meet at the 2011 BIO International Convention in Washington, DC next week, I’m pleased to announce that we’ve re-launched BIOtechNOW as a multi-blog platform. Our new platform aims to create an online biotech community where we can connect to discuss the latest industry news – kind of like our convention, but available online 365 days a year. BIOtechNOW will be a critical component of our advocacy, education and business Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Sickle Cell Anemia: Three ways to help end it

SickleCellAnemia

Sickle Cell Anemia is the most common genetic disease in the United States. It affects more than 80,000 people in America and the trait for the disease is known to be carried by one in 12 African Americans. For those living with the disease, suffering from a sickle cell crisis can be debilitating, reducing a person into a state of intense pain, which often means trips to the hospital that typically last six days. There Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Beware the Liability Gaps in Biotechnology M&As

Mike Yeager, Senior Underwriting Specialist, Chubb Mergers and acquisitions continue to be a source of growth for the biotechnology industry. Even the financial crisis has not significantly slowed this trend. In fact, a weakened global economy may have further fueled consolidation as biotechnology companies sought additional efficiencies in R&D, procurement or administration. Since many biotechnology companies have complex corporate structures—some with hundreds of subsidiaries—executives at acquiring companies recognize that along with the benefits of the Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,